— Know what they know.
Not Investment Advice
Also trades as: ILM1.DE (XETRA) · $vol 0M · 0QB4.L (LSE) · $vol 0M

MEDOF OTC

Medios AG
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: +0.0%
$50.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 49 · $1.3B mcap · 8M float · 0.019% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.3B
52W Range13.64-50
Volume2,000
Avg Volume1,600
Beta1.30
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOThomas Meier
Employees993
SectorHealthcare
IndustryMedical - Distribution
IPO Date2021-11-10
Heidestrasse 9
Berlin 10557
DE
49 30 232 5668 00
About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms